- Low
- 51,225
- Average
- 51,225
- Median
- 51,225
- High
- 51,225
Lpath Salary
66
53
39
Lpath average salary is $51,225, median salary is $51,225 with a salary range from $51,225 to $51,225.
Lpath salaries are collected from government agencies and companies. Each salary is associated with a real job position. Lpath salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Lpath salaries are collected from government agencies and companies. Each salary is associated with a real job position. Lpath salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
| Job Title | Salaries | City | Year | More info |
| Field Engineer | 51,225-51,225 | Lynchburg, VA, 24501 | 2014 | Lpath Field Engineer Salaries (1) Lpath Lynchburg, VA Salaries |
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Lpath salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Lpath Jobs
| See more Lpath Jobs» | |
| Search All Jobs | |
Patents information
243
All Patents
48
Grant Patents
170
Patents Pending
48
Patents Families
More Recent
Lpath... Information
- Lpath Inc.
- Industry: BioTech/Drugs
- City: San Diego, CA
- Lpath Therapeutics, Inc. is an emerging San Diego-based drug discovery company with a focus on bioactive lipids as targets for treating human diseases. Lpath's lead product candidate is a monoclonal antibody (mAb) against sphingosine-1-phosphate (S1P), an innovative target for cancer treatment. It is the first and only monoclonal antibody ever developed against any lysolipid, an extremely important subcategory of lipids. The antibody, SphingomabTM, has an unusually promising profile as a therapeutic candidate.The Company is now seeking support to do the following: (i) humanize the mouse mAb (ii) initiate formal preclinical development activities to permit a clinical evaluation of the antibody
